All lobbying filings

ACORN CONSULTING

ACORN CONSULTING filed a Q3 report for THORAGENIX INNOVATIONS, INC. on October 20, 2026, reporting $30,000 in lobbying income.

Lobbying for THORAGENIX INNOVATIONS, INC. · ThoraGenix is a medical device company focused on developing innovative surgical products.

All filings by ACORN CONSULTING · Everything THORAGENIX INNOVATIONS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Florida

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Advancing study and approval for medical devices

Defense

Advancing medical polices and device procurement in order to provide service members who have been traumatically injured in the field improved outcomes S. 4784, National Defense Authorization Act H.R. 8800, National Defense Authorization Act

Bills named in this filing 2

S. 4784
National Defense Authorization Act for Fiscal Year 2027
H.R. 8800
National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.